Cargando…
Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
Lipid-polymer hybrid nanoparticles (LPHNP) are delivery systems for controlled drug delivery at tumor sites. The superior biocompatible properties of lipids and structural advantages of polymers can be obtained using this system for controlled drug delivery. In this study, cisplatin-loaded lipid-chi...
Autores principales: | Khan, Muhammad Muzamil, Madni, Asadullah, Torchilin, Vladimir, Filipczak, Nina, Pan, Jiayi, Tahir, Nayab, Shah, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711028/ https://www.ncbi.nlm.nih.gov/pubmed/31357896 http://dx.doi.org/10.1080/10717544.2019.1642420 |
Ejemplares similares
-
Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
por: Khan, Muhammad Muzamil, et al.
Publicado: (2020) -
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
por: Tahir, Nayab, et al.
Publicado: (2019) -
Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug Delivery
por: Parveen, Farzana, et al.
Publicado: (2022) -
Lipid-Based Drug Delivery Systems in Regenerative Medicine
por: Filipczak, Nina, et al.
Publicado: (2021) -
Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers
por: Subhan, Md Abdus, et al.
Publicado: (2023)